Applied DNA Sciences (APDN, $8.89) gets FDA nod on emergency clinical use of its covid-19 test
Applied DNA Sciences got an authorization from the U.S. Food and Drug Administration (FDA) for emergency clinical use of its covid-19 test, Linea.
"This extraordinary achievement highlights the company’s commitment to combating the covid-19 pandemic both locally and nationwide," Chief Executive James Hayward said in a statement.
The machine that performs the test can process 94 samples per hour and more than 2,000 tests per day. The FDA has authorized emergency use for about 50 molecular tests that can detect COVID-19
APDN in upward trend: price rose above 50-day moving average on September 26, 2025
APDN moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend. In of 27 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for APDN crossed bullishly above the 50-day moving average on October 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where APDN advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 55 cases where APDN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 28 cases where APDN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
APDN broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Advertisement
General Information
a provider of botanical deoxyribonucleic acid based security and authentication solutions
Industry MedicalSpecialties
Advertisement